High-Risk Patients Awaiting Liver Transplant Benefit Most From Living Donors
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — High-risk cirrhosis patients awaiting liver transplant (LT) most benefit from potential living donors, according to a study published online Sept. 2 in Aging.Fakhar Ali Qazi Arisar, M.B.B.S., from the Unive…
Learn MoreSarcopenia Worsens Liver Transplant Outcomes for Patients With Cirrhosis
THURSDAY, Oct. 5, 2023 (HealthDay News) — Sarcopenia is associated with adverse outcomes after liver transplantation (LT) in patients with decompensated cirrhosis (DC), according to a study published online Sept. 21 in the Journal of Cachexia, Sarcop…
Learn MoreSarcopenia Worsens Liver Transplant Outcomes for Patients With Cirrhosis
THURSDAY, Oct. 5, 2023 (HealthDay News) — Sarcopenia is associated with adverse outcomes after liver transplantation (LT) in patients with decompensated cirrhosis (DC), according to a study published online Sept. 21 in the Journal of Cachexia, Sarcop…
Learn MoreRelacionan consumo excesivo de alcohol con cúmulos peligrosos de grasa en hígado y corazón
MARTES, 19 de septiembre de 2023 (HealthDay News) — Antes de servirse otra bebida, considere esta nueva investigación: Los bebedores empedernidos pueden desarrollar grasa alrededor del corazón, lo que lleva a insuficiencia cardíaca y otros problemas …
Learn MoreHeavy Drinking Tied to Dangerous Buildup of Fat Around Heart, Liver
MONDAY, Sept. 18, 2023 (HealthDay News) — Before pouring another drink, consider this sobering new research: Heavy drinkers can develop fat around the heart, leading to heart failure and other cardiac problems.This so-called pericardial fat is associ…
Learn MoreHepatitis C Virus Still Leading Cause of Hepatocellular Cancer in Men
THURSDAY, Sept. 7, 2023 (HealthDay News) — The leading cause of hepatocellular carcinoma (HCC) is still hepatitis C virus (HCV) among men, but the rates of HCV-HCC have decreased since 2015, according to a study published online Sept. 5 in Clinical G…
Learn MoreRates of Tx Retention for Rifaximin Low Despite Benefits for Hepatic Encephalopathy
FRIDAY, Sept. 1, 2023 (HealthDay News) — Rates of rifaximin treatment retention are low despite the known benefits of rifaximin use for breakthrough hepatic encephalopathy (HE), according to a study published in the August issue of Hepatology Communi…
Learn MoreTechnical Variant Graft Usage Affects Pediatric Liver Transplant Waitlist Mortality
FRIDAY, July 21, 2023 (HealthDay News) — For pediatric liver transplant (LT) candidates, higher technical variant graft (TVG; including living donor [LD] and deceased donor split/partial grafts) usage is associated with lower waitlist (WL) mortality,…
Learn MoreRecommendations Developed for Management of Acute Liver Failure
WEDNESDAY, July 12, 2023 (HealthDay News) — In a clinical guideline issued by the American College of Gastroenterology and published in the July issue of the American Journal of Gastroenterology, recommendations are presented for the identification,…
Learn MoreHepatitis C Treatments: A Comprehensive Guide
THURSDAY, July 6, 2023 (HealthDay News) — Did you know the U.S. Centers for Disease Control and Prevention estimates that there were nearly 68,000 new cases of acute hepatitis C in 2020 and over 107,000 newly reported cases of chronic hepatitis C?To …
Learn More